All In MedTech

Device Trial Radar · NCT06581393

First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings

Last checked: Nov 20, 2026Latest source record: Jun 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Dec 9, 2024

Primary completion

Apr 28, 2025

Study completion Apr 28, 2025

Sponsor

Lead sponsor
Diality Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 3, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a non-significant risk study utilizing a device cleared for use by the FDA under its 510(k) clearance. Consented patients will complete their usual dialysis treatment under professional care in an ICHD (In-Center Hemodialysis) setting.

Conditions

  • End Stage Renal Disease
  • End Stage Renal Disease on Dialysis
  • End Stage Kidney Disease

Interventions

  • Moda-flx Hemodialysis SystemDevice

    All participants will complete up to 4 dialysis treatments on the Moda-flx Hemodialysis System over a period of up to 2 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Single-Pool Standardized Dialysis AdequacyTime frame: Samples will be collected before and after each dialysis treatment at Visit 1, Visit 2, Visit 3 and at Visit 4 over a two week period
  2. Changes in Blood ChemistryTime frame: Samples will be collected at Visit 1 prior to initiating the first dialysis treatment, Visit 2, Visit 3 and at the conclusion of Visit 4 over a two week period
  3. Changes in Complete Blood CountTime frame: Samples will be collected at Visit 1 prior to initiating the first dialysis treatment, Visit 2, Visit 3 and at the conclusion of Visit 4 over a two week period

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • North America Research Institute

    Ontario, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.